Global Styrenic Polymers Market for Medical Applications: Snapshot

Styrenic polymers, or styrenics, are a class of the plastics family, with styrene as the main building block. Polystyrene is the parent material for all styrenic copolymers. It is a widely utilized thermoplastic material. It is employed in various end-user industries such as automotive, building & construction, electrical & electronics, and medical among many others.

Styrenic polymers that are employed in medical applications include polystyrene (PS), acrylonitrile butadiene styrene (ABS), styrene acrylonitrile (SAN), styrene butadiene block copolymers (SBC), styrene methyl methacrylate (SMMA), and others. Styrenic polymers are employed in various applications in the medical industry. For instance, these are utilized in the manufacture of surgical instruments, portable medical devices, liquid containers, connector tubes, and bags.

Restrictions on PVC in medical applications have benefitted other plastics such as styrenic polymers. A new family of hydrogenated SBCs has found new applications in the medical market. According to the U.S. FDA, thermoplastic elastomers (TPEs) are best suited for applications that require UV stability, and are safe to be utilized in medical devices and equipment. Styrene block copolymers are halogen and plasticizer-free materials with superior abrasion resistance. These exhibit good mechanical performance. This shift in trend toward lower reliance on PVC materials is a major factor driving the medical styrenics market.

Styrenic polymers offer several functional and environmental advantages over other plastic families such as PVC, polypropylene, and polyethylene. However, the higher price of common styrenic polymers (such as polystyrene and ABS) over its competitors restrains the market to some extent. The price sensitive nature of the market, especially in Asia Pacific, is anticipated to hamper the market for styrenic polymers due to its high prices. However, the prices of styrenic polymers are estimated to decline due to the rapid fall in prices of raw materials in recent years. This is projected to boost the demand for styrenic polymers.

global styrenic polymers market

Europe, North America, and Asia Pacific Held Dominant Share in Overall Market

In terms of demand, Europe, Asia Pacific, and North America collectively accounted for more than 80% share of the TBHP market in 2016. Japan, South Korea, Taiwan, China, the U.S., Germany, Netherlands, Spain, and Belgium are some of the major countries producing styrenic polymers. Various styrenic polymers are also exported in comparatively small amounts by countries such as Jordan, Indonesia, the Philippines, Turkey, Portugal, the UAE, and Argentina.

In terms of growth potential, Asia Pacific, followed by MEA, is expected to lead the global market during the forecast period. Asia Pacific is the leading region in the market in terms of volume as well as growth potential. A major factor ascribing to the trend is the consumption of different styrenic polymers in China. The country is a prominent consumer of several polymers. The market in Europe is expected to witness sluggish growth due to mature conditions; however, environmental regulations can heavily affect the market in the region. Eastern Europe is anticipated to exhibit higher lucrative opportunities, as compared to central and western Europe.

Medical device and medical packaging manufacturers procure styrenic polymers of different grades and qualities. Low degree of integration exists between styrenic polymer manufacturers and final product manufacturers. The styrenic polymers market is fairly consolidated, with some companies accounting for a significant share of the market. The volume of styrenic polymers used in medical applications is less, as compared to its primary applications in automotive and building & construction industries.

INEOS STYROLUTION Group GmbH is a leading manufacturer of styrenic polymers for medical applications in the market. Other notable manufactures include LG Chem Ltd., Chi Mei Corporation, Chevron Phillips Chemical Company LLC, Kraton Corporation, Trinseo LLC, TSRC Corporation, and SABIC. The styrenic polymers market for medical applications is moderately consolidated in nature, with the top few companies occupying considerable market share.

Report Description

Global Styrenic Polymers Market for Medical Applications: Overview

Styrenic polymers, or styrenics, are a class of the plastics family, with styrene as the main building block. Polystyrene is the parent material for all styrenic copolymers. It is a widely utilized thermoplastic material. It is employed in various end-user industries such as automotive, building & construction, electrical & electronics, and medical among many others.

Styrenic polymers provide several benefits to diverse requirements of the medical industry. Styrenic materials can be processed to be rigid as well as flexible as per the end-use requirements. Styrenic polymers provide unique advantages for design and development of medical devices and parts due to their flexibility. Chemical inertness, unique bonding polarity, and physical and aesthetic properties augur well for the styrenic polymers in medical applications. However, styrenic polymers are relatively more expensive than their counterparts such as PVC, polyethylene, and polypropylene that dominate the overall medical polymers market.

Environmental factors play a role in the manufacture and marketing of all medical plastics. Manufacture of styrenic polymers for medical applications is a capital- and technology-intensive process that requires robust infrastructure and technology services. Government regulations pertaining to different medical devices govern the market for medical plastics. The quality of a product is of utmost importance and stringent quality standards need to be adhered to.

The styrenic polymer for medical applications market is governed by several value-adding services that run in the background. Research and development is the cornerstone of the market dynamics with evolving consumer requirements and threat from substitute products.

Global Styrenic Polymers Market for Medical Applications: Scope of the Study

The report estimates and forecasts the styrenic polymers for medical applications market on the global and regional levels. The study provides forecast between 2017 and 2025 based on volume (tons) and revenue (US$ Mn) with 2016 as the base year. The report comprises an exhaustive value chain analysis, along with a comprehensive view of the market. Value chain analysis also offers detailed information about value addition at each stage. The study includes drivers and restraints for the styrenic polymers for medical applications market, along with their impact on demand during the forecast period. The study also provides key market indicators affecting the growth of the market. The report analyzes opportunities in the styrenic polymers for medical applications market on the global and regional level. Drivers, restraints, and opportunities mentioned in the report are justified through quantitative and qualitative data. These have been verified through primary and secondary resources. Furthermore, the report analyzes substitute analysis of Styrenic polymers for medical applications and global average price trend analysis.

The report includes Porter’s Five Forces Model to determine the degree of competition in the styrenic polymers for medical applications market. The report comprises a qualitative write-up on market attractiveness analysis, wherein end-users and regions have been analyzed based on attractiveness for each region. Growth rate, market size, raw material availability, profit margin, impact strength, technology, competition, and other factors (such as environmental and legal) have been evaluated in order to derive the general attractiveness of the market. The report comprises price trend analysis for styrenic polymers for medical applications market between 2017 and 2025.

Global Styrenic Polymers Market for Medical Applications: Research Methodology

Secondary research sources that were typically referred to include, but were not limited to, British Plastics Federation, EUROPA - European Commission National government documents, statistical databases, and market reports, European Chemicals Agency (ECHA), PlasticsEurope, Regulation on Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), U.S. Food and Drug Administration (U.S. FDA), Independent Chemical Information Service (ICIS), Chemical Weekly Magazine, U.N. Comtrade, World Bank, national government documents, statistical databases, and market reports, company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings. Other sources such as internal and external proprietary databases, statistical databases and market reports, news articles, national government documents, and webcasts specific to companies operating in the market have also been referred for the report.

In-depth interviews and discussions with a wide range of key opinion leaders and industry participants were conducted to compile this research report. Primary research represents the bulk of research efforts, supplemented by extensive secondary research. Key players’ product literature, annual reports, press releases, and relevant documents were reviewed for competitive analysis and market understanding. This helped in validating and strengthening secondary research findings. Primary research further helped in developing the analysis team’s expertise and market understanding.

Global Styrenic Polymers Market for Medical Applications: Key Segments

The study provides a comprehensive view of the styrenic polymers for medical applications market by dividing it into product, application and geography segments. The product segments are PS, ABS, SAN, SBC, SMMA, and others. The applications are segmented into intra-venous systems & fluid delivery, mobile & digital health, surgical gloves, respiratory & drug delivery devices, and others. These segments have been analyzed based on historic, present, and future trends.

Regional segmentation includes the current and forecast consumption of styrenic polymers for medical applications in North America, Latin America, Europe, Asia Pacific, and Middle East & Africa (MEA). Market segmentation includes demand for consumption in all the regions individually.

Companies Mentioned in Report

The report covers detailed competitive outlook that includes market share and profiles of key players operating in the global market. Key players profiled in the report include INEOS STYROLUTION Group GmbH, LG Chem Ltd., Chi Mei Corporation, Chevron Phillips Chemicals Company LLC, Kraton Corporation, Trinseo LLC, TSRC Corporation, and SABIC. Company profiles include attributes such as company overview, number of employees, brand overview, business overview, business strategies, recent/key developments, acquisitions, financial overview, and product details (wherever applicable).

The global styrenic polymers for medical applications market has been segmented as follows:

Styrenic Polymers Market for Medical Applications – Product Analysis

  • Polystyrene (PS)
  • Acrylonitrile Butadiene Styrene (ABS)
  • Styrene Acrylonitrile (SAN)
  • Styrene Butadiene Block Copolymers (SBC)
  • Styrene Methyl Methacrylate (SMMA)
  • Others

Styrenic Polymers Market for Medical Applications – Application Analysis

  • Intra-venous Systems & Fluid Delivery
  • Mobile & Digital Health
  • Surgical Gloves
  • Respiratory & Drug Delivery Devices
  • Others

Styrenic Polymers Market for Medical Applications – Regional Analysis

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • U.K.
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
.